NCT07504796
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07504796
Title ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
Recruitment Not yet recruiting
Gender both
Phase Expanded access
Variant Requirements No
Sponsors NYU Langone Health
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.